{
    "clinical_study": {
        "@rank": "157906", 
        "arm_group": [
            {
                "arm_group_label": "KM110329", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive KM110329 for eight weeks. Participants will take 2 tablets by mouth with water two times a day after meals."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Participants will receive placebo drug for eight weeks. Participants will take 2 tablets by mouth with water two times a day after meals."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine clinical efficacy and safety of KM110329 for\n      Atopic dermatitis."
        }, 
        "brief_title": "KM110329 in Adult Patients With Atopic Dermatitis", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Atopic Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic"
            ]
        }, 
        "detailed_description": {
            "textblock": "A randomized, double blind, placebo-controlled, multicenter trial will be conducted at the\n      Seoul St.Mary's Hospital, at Chung-ang University hospital, and at Kyung Hee University\n      Hospital at Gangdong.\n\n      Participants fulfilling eligibility criteria will be selected. Enrolled participants will be\n      randomly allocated to two parallel groups: the KM110329 and placebo arms.\n\n      Each participant will be examined for signs and symptoms of Atopic dermatitis before and\n      after taking functional food."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women ages 18 to 65 years\n\n          -  Individuals who diagnosed Atopic dermatitis according to the criteria of Hanifin and\n             Rajka\n\n          -  Individuals who mild to moderate atopic dermatitis (objective SCORAD\u226440)\n\n          -  Written informed consent for participation in the trial\n\n        Exclusion Criteria:\n\n          -  Severe skin disease other than Atopic dermatitis\n\n          -  Secondary infection with bacteria, fungi, and virus\n\n          -  Uncontrolled hypertension (SBP > 145 mmHg or DBP > 95 mmHg)\n\n          -  Severe liver disability (2.5-fold the normal high range value for ALT, AST)\n\n          -  Severe renal disability (sCr > 2.0mg/dl)\n\n          -  Women who are pregnant, lactating, planning a pregnancy or women of child-bearing age\n             who do not agree to proper contraception\n\n          -  Use of oral steroids, oral antibiotic or other immunosuppressants within the past 4\n             weeks\n\n          -  Treated by systemic photochemotherapy within past 4 weeks\n\n          -  History of drug abuse\n\n          -  Hypersensitivity to Rubi Fructus, Houttuyniae Herba, Rehmanniae Radix, Betulae\n             Platyphyllae Cortex\n\n          -  Use of other investigational products within the past two months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01692093", 
            "org_study_id": "CCRG_KM110329"
        }, 
        "intervention": [
            {
                "arm_group_label": "KM110329", 
                "description": "KM110329, a functional food consist of four herbs which are shown to be beneficial for skin health", 
                "intervention_name": "KM110329", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "SCORAD", 
            "Atopic dermatits", 
            "Skin health"
        ], 
        "lastchanged_date": "November 12, 2013", 
        "location": {
            "contact": {
                "email": "pm.thehoo@gmail.com", 
                "last_name": "CHUNHOO CHEON, M.D.(DKM)", 
                "phone": "82-2-961-9278"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "130-701"
                }, 
                "name": "Kyung Hee University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "KM110329 in Adult Patients With Atopic Dermatitis : a Randomised, Double-blind, Placebo-controlled, Multicenter Trial", 
        "other_outcome": [
            {
                "description": "Transepidermal Water Loss", 
                "measure": "TEWL", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "hydration in the stratum corneum", 
                "measure": "hydration in the stratum corneum", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Evaluation endpoint for clinical trial of herbal medicinal products about atopic dermatitis", 
                "measure": "KiFDA-HM-AD", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Kyung Hee University", 
            "last_name": "SEONG GYU KO, M.D.(DKM)", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "SCORing Atopic Dermatitis", 
            "measure": "SCORAD index", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01692093"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kyunghee University Medical Center", 
            "investigator_full_name": "Seong-Gyu Ko", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The Dermatology Life Quality Index", 
            "measure": "DLQI", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "source": "Kyunghee University Medical Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "St Mary's Hospital, London", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chung-Ang University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kyung Hee University Gangdong Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Kyunghee University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}